Co-Authors
This is a "connection" page, showing publications co-authored by ISABELLE BEDROSIAN and ANJANA BHARDWAJ.
Connection Strength
5.063
-
The molecular heterogeneity of the precancerous breast affects drug efficacy. Sci Rep. 2022 07 22; 12(1):12590.
Score: 0.886
-
Gene signature associated with resistance to fluvastatin chemoprevention for breast cancer. BMC Cancer. 2022 Mar 17; 22(1):282.
Score: 0.865
-
Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer. Breast Cancer Res Treat. 2021 Jun; 187(2):363-374.
Score: 0.813
-
The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer. Breast Cancer Res. 2018 12 11; 20(1):150.
Score: 0.690
-
Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer. Oncotarget. 2017 Mar 21; 8(12):19645-19660.
Score: 0.612
-
Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling. PLoS One. 2015; 10(5):e0127678.
Score: 0.539
-
Suppression of Akt-mTOR pathway-a novel component of oncogene induced DNA damage response barrier in breast tumorigenesis. PLoS One. 2014; 9(5):e97076.
Score: 0.502
-
Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer. Front Immunol. 2023; 14:1188831.
Score: 0.060
-
Erratum: Ju, Z., et al. Integrative Analyses of Multilevel Omics Reveal Preneoplastic Breast to Possess a Molecular Landscape That Is Globally Shared with Invasive Basal-Like Breast Cancer (Running Title: Molecular Landscape of Basal-Like Breast Cancer Progression). Cancers 2020, 12, 722. Cancers (Basel). 2020 Oct 20; 12(10).
Score: 0.049
-
Integrative Analyses of Multilevel Omics Reveal Preneoplastic Breast to Possess a Molecular Landscape That is Globally Shared with Invasive Basal-Like Breast Cancer (Running Title: Molecular Landscape of Basal-Like Breast Cancer Progression). Cancers (Basel). 2020 Mar 19; 12(3).
Score: 0.047